Why the study?
A genetic cause is found in 30% of NCCM patients with variable clinical features, motivating an investigation into genotype-phenotype correlations.
What are the genotype-phenotype correlations and their impact on MACE risk in patients with noncompaction cardiomyopathy?
What are the genotype-phenotype correlations and their impact on MACE risk in patients with noncompaction cardiomyopathy?
Genotype-phenotype correlations in noncompaction cardiomyopathy reveal that sarcomere gene mutations are common in adults with lower MACE risk, while children face multi-systemic disorders with severe outcomes, highlighting the importance of DNA diagnostics for clinical management.
Answers are grounded in this paper and cite their sources.
DNA diagnostics may aid MACE risk stratification in NCCM; extends observational genotype-phenotype data but needs prospective validation.
Background A genetic cause can be identified in 30% of noncompaction cardiomyopathy patients (NCCM) with clinical features ranging from asymptomatic cardiomyopathy to heart failure with major adverse cardiac events (MACE). Methods and Results To investigate genotype-phenotype correlations, the genotypes and clinical features of genetic NCCM patients were collected from the literature. We compared age at diagnosis, cardiac features and risk for MACE according to mode of inheritance and molecular effects for defects in the most common sarcomere genes and NCCM subtypes. Geno- and phenotypes of 561 NCCM patients from 172 studies showed increased risk in children for congenital heart defects (P<0.001) and MACE (P<0.001). In adult NCCM patients the main causes were single missense mutations in sarcomere genes. Children more frequently had an X-linked or mitochondrial inherited defect (P=0.001) or chromosomal anomalies (P<0.001). MYH7 was involved in 48% of the sarcomere gene mutations. MYH7 and ACTC1 mutations had lower risk for MACE than MYBPC3 and TTN (P=0.001). The NCCM/dilated cardiomyopathy cardiac phenotype was the most frequent subtype (56%; P=0.022) and was associated with an increased risk for MACE and high risk for left ventricular systolic dysfunction (<0.001). In multivariate binary logistic regression analysis MYBPC3, TTN, arrhythmia -, non-sarcomere non-arrhythmia cardiomyopathy-and X-linked genes were genetic predictors for MACE. Conclusions Sarcomere gene mutations were the most common cause in adult patients with lower risk of MACE. Children had multi-systemic disorders with severe outcome, suggesting that the diagnostic and clinical approaches should be adjusted to age at presentation. The observed genotype-phenotype correlations endorsed that DNA diagnostics for NCCM is important for clinical management and counseling of patients.
No takes yet. Share an insight, caveat, or question.
Waning et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: